Fibrocell Science Inc

Ticker FCSC

Exchange NASDAQ More
Industry Drugs - Generic More
Sector Healthcare More

51-200 Employees
Based in Exton, Pennsylvania

Fibrocell Science, Inc., an autologous cell therapy company, focuses on developing treatments for skin and connective tissue diseases with unmet medical needs. The company, through its proprietary autologous fibroblast technology, develops azficel-T, which is in Phase II clinical trials for the treatment of vocal cord scarring and restrictive burn scarring.

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (199)

Fibrocell Science Inc reports have an aggregate usefulness score of 4.8 based on 199 reviews.

Fibrocell Science Inc

Most Recent Annual Report

MOST RECENT 2018 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Fibrocell Science Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.